These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16615535)

  • 41. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
    Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
    Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
    [No Abstract]   [Full Text] [Related]  

  • 42. [Serological diagnosis of infectious mononucleosis caused by Epstein-Barr virus].
    de Ory F
    Enferm Infecc Microbiol Clin; 1991 Jan; 9(1):63-4. PubMed ID: 1851444
    [No Abstract]   [Full Text] [Related]  

  • 43. [Significance of the Epstein-Barr virus and cytomegalovirus antibody demonstration in the diagnosis of infectious mononucleosis].
    Schmitz H
    Verh Dtsch Ges Inn Med; 1972; 78():930-3. PubMed ID: 4353157
    [No Abstract]   [Full Text] [Related]  

  • 44. [Antibodies to the Epstein-Barr virus in pregnant women with suspected teratogenic virus infection].
    Vojtĕchovský K
    Cesk Pediatr; 1982 Nov; 37(11):653. PubMed ID: 6293726
    [No Abstract]   [Full Text] [Related]  

  • 45. [Demonstration of Epstein-Barr virus capsid antigen (VCA) in lymphocyte cultures from patients with mononucleosis].
    Szucs G; Ternák G
    Orv Hetil; 1977 Aug; 118(32):1891-2. PubMed ID: 196242
    [No Abstract]   [Full Text] [Related]  

  • 46. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Letter: Epstein-Barr viral antibodies and leukocyte-transforming agent in infectious mononucleosis.
    Chang RS; Cooper TY; Simpson EE
    N Engl J Med; 1976 Jun; 294(25):1404-5. PubMed ID: 177877
    [No Abstract]   [Full Text] [Related]  

  • 48. Failure to detect heterophile antigens in Epstein-Barr virus-infected cells and to demonstrate interaction of heterophile antibodies with Epstein-Barr virus.
    Henle W; Henle G; Hewetson J; Rocchi G; Leikola J
    Clin Exp Immunol; 1974 Jun; 17(2):281-6. PubMed ID: 4377415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A living-related kidney donor as the source of a nearly fatal primary Epstein-Barr virus infection following transplantation.
    van Gelder T; Kroes LC; Mulder A; Gratama JW; Weimar W
    Transplantation; 1994 Oct; 58(7):852-5. PubMed ID: 7940722
    [No Abstract]   [Full Text] [Related]  

  • 50. Infectious mononucleosis and Epstein-Barr virus in childhood.
    Tamir D; Benderly A; Levy J; Ben-Porath E; Vonsover A
    Pediatrics; 1974 Mar; 53(3):330-5. PubMed ID: 4360931
    [No Abstract]   [Full Text] [Related]  

  • 51. [The Epstein-Barr virus infects immunologic cells].
    Ernberg I; Britton S
    Lakartidningen; 1983 Feb; 80(8):689-92. PubMed ID: 6306366
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum concentrations of interferon gamma, interleukin-6 and neopterin in patients with infectious mononucleosis and other Epstein-Barr virus-related lymphoproliferative diseases.
    Schuster V; Herold M; Wachter H; Reibnegger G
    Infection; 1993; 21(4):210-3. PubMed ID: 8225623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.
    Purtilo DT
    Springer Semin Immunopathol; 1991; 13(2):181-97. PubMed ID: 1664985
    [No Abstract]   [Full Text] [Related]  

  • 54. Epstein-Barr virus and lymphoproliferative disorders.
    Sullivan JL
    Semin Hematol; 1988 Jul; 25(3):269-79. PubMed ID: 2841766
    [No Abstract]   [Full Text] [Related]  

  • 55. Registry of fatal infectious mononucleosis and Epstein-Barr virus infections.
    Purtilo DT
    JAMA; 1980 May; 243(18):1806. PubMed ID: 6245285
    [No Abstract]   [Full Text] [Related]  

  • 56. Epstein-Barr virus and the immune response.
    Thompson PJ
    Lancet; 1983 Jan; 1(8314-5):70. PubMed ID: 6129403
    [No Abstract]   [Full Text] [Related]  

  • 57. Epstein-Barr virus infection and immunoregulation in man.
    Tosato G; Blaese RM
    Adv Immunol; 1985; 37():99-149. PubMed ID: 2988307
    [No Abstract]   [Full Text] [Related]  

  • 58. Epstein-Barr virus-associated lymphocytic cholangitis in a child with X-linked lymphoproliferative syndrome.
    Bhattarai D; Vignesh P; Kaur A; Kumari P; V Menon J; Geethanjali G; Rawat A
    Scand J Immunol; 2021 Feb; 93(2):e12975. PubMed ID: 32897580
    [No Abstract]   [Full Text] [Related]  

  • 59. The Epstein-Barr virus in autoimmunity.
    Vaughan JH
    Springer Semin Immunopathol; 1995; 17(2-3):203-30. PubMed ID: 8571169
    [No Abstract]   [Full Text] [Related]  

  • 60. The Epstein-Barr virus as a model of virus-host interactions.
    Rickinson AB; Yao QY; Wallace LE
    Br Med Bull; 1985 Jan; 41(1):75-9. PubMed ID: 2982449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.